Clinical Trial: Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis

U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07800351) titled 'Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis' on Aug. 29.

Brief Summary: The goal of this clinical trial is to learn about the effects of adding nicorandil to conventional Disease-Modifying Antirheumatic Drugs(DMARDs) in treatment of patients with rheumatoid arthritis. The main questions it aims to answer are:

Does adding nicorandil to conventional DMARDs in treatment of patients with rheumatoid arthritis reduce the risk of plaque buildup in arteries (atherosclerosis) ? and What medical problems may participants have when taking nicorandil ?

Participants will:

Take nicorandil added to DMARDs or DMARDs ...